GILD - GILEAD SCIENCES, INC.
99.57
-0.750 -0.753%
Share volume: 208,801
Last Updated: Wed 05 Feb 2025 08:30:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.19%
PREVIOUS CLOSE
CHG
CHG%
$100.32
-0.75
-0.75%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-03 | 2023-08-04 | 2023-11-07 | 2024-02-23 | 2024-05-08 | 2024-05-08 | 2024-08-08 | 2024-11-12 | |
| Assets | |||||||||
| Total Assets | 61.876 B | 62.337 B | 62.373 B | 62.125 B | 56.292 B | 56.291 B | 53.579 B | 54.525 B | |
| Current Assets | 13.456 B | 14.286 B | 15.979 B | 16.085 B | 14.041 B | 14.040 B | 12.317 B | 14.779 B | |
| Inventories | 1.576 B | 1.633 B | 1.663 B | 1.787 B | 1.853 B | 1.853 B | 2.026 B | 1.869 B | |
| Other Current Assets | 1.846 B | 1.757 B | 2.662 B | 2.374 B | 0.000 | 1.459 B | 0.000 | 0.000 | |
| Short Term Investments | 1.846 B | 1.757 B | 2.662 B | 2.374 B | 0.000 | 1.459 B | 0.000 | 0.000 | |
| Total Receivables | 4.162 B | 4.229 B | 4.790 B | 4.660 B | 0.000 | 4.669 B | 0.000 | 0.000 | |
| Current Cash | 5.872 B | 6.667 B | 6.864 B | 7.264 B | 4.718 B | 6.059 B | 2.772 B | 5.037 B | |
| Total Non-current Assets | 48.420 B | 48.051 B | 46.394 B | 46.040 B | 0.000 | 42.251 B | 0.000 | 0.000 | |
| Property Plant Equipment | 5.479 B | 5.540 B | 5.572 B | 5.317 B | 5.321 B | 5.321 B | 5.346 B | 5.391 B | |
| Other Assets | 4.952 B | 5.113 B | 3.863 B | 4.452 B | 36.930 B | 4.044 B | 35.916 B | 34.354 B | |
| Intangible Assets | 28.348 B | 27.750 B | 27.152 B | 26.454 B | 0.000 | 23.428 B | 0.000 | 0.000 | |
| Goodwill | 8.314 B | 8.314 B | 8.314 B | 8.314 B | 0.000 | 8.314 B | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 61.876 B | 62.337 B | 62.373 B | 62.125 B | 56.292 B | 56.291 B | 53.579 B | 54.525 B | |
| Total liabilities | 40.878 B | 41.179 B | 40.058 B | 39.292 B | 38.837 B | 38.754 B | 35.384 B | 36.134 B | |
| Total current liabilities | 10.527 B | 13.964 B | 11.945 B | 11.280 B | 13.015 B | 13.016 B | 10.781 B | 11.725 B | |
| Accounts Payable | 627.000 M | 622.000 M | 586.000 M | 550.000 M | 622.000 M | 622.000 M | 537.000 M | 903.000 M | |
| Other liabilities | 5.052 B | 3.964 B | 3.012 B | 3.319 B | 1.395 B | 3.362 B | 1.418 B | 1.396 B | |
| Current long term debt | 2.283 B | 4.037 B | 1.793 B | 1.798 B | 0.000 | 3.667 B | 0.000 | 0.000 | |
| Long term debt | 22.956 B | 21.209 B | 23.189 B | 23.189 B | 21.527 B | 21.527 B | 21.540 B | 21.437 B | |
| Other liabilities | 5.052 B | 3.964 B | 3.012 B | 3.319 B | 1.395 B | 3.362 B | 1.418 B | 1.396 B | |
| Minority interest | -58.000 M | -64.000 M | -72.000 M | -84.000 M | 0.000 | -84.000 M | 0.000 | 0.000 | |
| Total Shareholder equity | 20.997 B | 21.157 B | 22.313 B | 22.833 B | 17.539 B | 17.539 B | 18.281 B | 18.474 B | |
| Common stock | 1.248 B | 1.249 B | 1.248 B | 1.247 B | 6.814 B | 1.247 B | 7.023 B | 7.328 B | |
| Retained earnings | 15.223 B | 15.138 B | 16.002 B | 16.304 B | 10.656 B | 10.656 B | 11.165 B | 11.073 B |